From todays New York Times
https://www.nytimes.com/2023/12/22/business/bristol-myers-karuna-drug-deal.html?unlocked_article_code=1.H00.vxXg.iotBVsqVzzn5&smid=url-share
- Forums
- ASX - By Stock
- NEU
- Bristol Myers to acquire Karuna for $14Billion
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.53%
!
$14.19

Bristol Myers to acquire Karuna for $14Billion
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.19 |
Change
0.075(0.53%) |
Mkt cap ! $1.759B |
Open | High | Low | Value | Volume |
$14.11 | $14.29 | $13.85 | $1.691M | 119.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 288 | $14.18 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.20 | 66 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 51 | 14.180 |
7 | 621 | 14.170 |
7 | 720 | 14.160 |
6 | 1262 | 14.150 |
8 | 5204 | 14.140 |
Price($) | Vol. | No. |
---|---|---|
14.200 | 211 | 3 |
14.210 | 513 | 3 |
14.220 | 1126 | 4 |
14.230 | 1464 | 5 |
14.240 | 1185 | 4 |
Last trade - 12.47pm 01/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online